Danish digital therapeutics company Brain+ is developing software-based platforms aimed at helping people affected by dementia and Alzheimer’s disease. The company’s mission is to restore patients’ independence and quality of life by detecting and treating dementia with digital technology. CEO Kim Baden-Kristensen joined the BioStock Investor Meeting to tell us more.

See the Brain+ presentation below.

Prenumerera på BioStocks nyhetsbrev